期刊文献+

COX-2在子宫内膜样腺癌中的表达及其与VEGF-C的相关性研究 被引量:1

Expression of COX-2 and Its Correlation with VEGF-C in Endometrioid Adenocarcinoma
下载PDF
导出
摘要 目的 探讨环氧化酶-2(C0X-2)和血管内皮生长因子C(VEGF-C)在子宫内膜样腺癌组织中的表达和相关性.方法 免疫组化SP法检测49例子宫内膜样腺癌、10例不典型增生及15例正常子宫内膜中COX-2和VEGF-C的表达,并结合临床病理特征进行分析,探讨二者表达的相关性.结果 COX-2和VEGF-C在正常子宫内膜组、子宫内膜不典型增生组和子宫内膜样腺癌组中阳性表达逐渐增高(P〈0.05).COX-2阳性表达与组织学分级有关(P〈0.05),VEGF-C的表达与手术病理分期、淋巴结转移、肌层浸润有关.COX-2与VEGF-C的表达存在正相关关系(r=0.392,P〈0.05).结论 COX-2可能通过PGE2上调VEGF-C的表达,两者共同促进了子宫内膜样腺癌的发生、发展和转移. Objective To study the expression level of Cyclooxygenase-2 ( COX-2 ) in normal endometrium, atypical hyperplasia of endometrium and endometrioid adenocarcinoma,and to explore its correlation with VEGF-C,in order to investigate its role and mechanism in the tumor genesis and development of endometrioid adenocarcinoma. Methods Forty-nine cases of endometrioid adenoearcinoma, ten cases of atypical hyperplasia of endometrium and fifteen cases of normal endometrium were selected in this study. Immunohistochemistry was used to detect the expression of COX-2, as well as VEGF-C. Results In normal endometrium, atypical hyperplasia of endometrium and endometrioid adenocarcinoma, the positive rate of COX-2 and VEGF-C was increased gradually. The expression of COX-2 correlated with histological grade ( P 〈 0.05 ) ,and the expression of VEGF-C correlated with FIGO stage, the depth of myometrial invasion and lymph node metastasis( P 〈 0. 05 ). There were positive correlation between the expression of COX-2and VEGF-C ( r =0. 392 ,P 〈 0.05 ). Conclusion Abnormal expression of COX-2 and VEGF-C closely relates with tumor genesis,development and metastasis of endometrioid adenocarcinoma. COX-2 may induce the expression of VEGF-C by PGE2.
出处 《潍坊医学院学报》 2010年第1期4-6,F0003,共4页 Acta Academiae Medicinae Weifang
关键词 子宫内膜肿瘤 环氧化酶-2 血管内皮生长因子C Endometrial neoplasms Cyclooxygenase-2 VEGF-C
  • 相关文献

参考文献9

  • 1Krysan K,Dalwadi H,Sharma S,et al.Cyelooxygenase-2 dependent expression of survivin is critical for apoptosis resistance in nonsmall cell lung cancer[J].Cancer Res,2004,64(18):6359-6362.
  • 2Burkhard HA,Von R,Hubert J.Coexpression of cyclooxygenases(COX-1,COX-2) and vascular endothelial growth factors(VEGF-A,VEGF-C) in esophageal adenocarcinoma[J].Cancer Res,2005,65(12):5038-5044.
  • 3Dursum P,Yuce K,Usubutun A.Cyclooxygenase-2 expression in cervical intraepithelial neoplasia Ⅲ and squamous cell cervical carcinoma,and its correlation with clinco pathologic variables[J].Int J Gynecol Cancer,2007,17(1):164-173.
  • 4李曙光,张昕,李明,扈东艳.子宫内膜癌组织中环氧化酶-2与雌、孕激素受体的表达及相关性研究[J].现代妇产科进展,2007,16(2):121-123. 被引量:3
  • 5Timoshenko AV,Rastogi S,Lala PK.Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer ceils[J].Br J Cancer,2007,97(8):1090-1098.
  • 6Ochi N,Matsuo Y,Sawai H,et al.Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis[J].Pancreas,2007,34(4):440-451.
  • 7Saintigny P,Kambouchner M,Ly M,et al.Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-smal1-cell lung cancer:concurrent expression in cancer ceils from primary tumor and metastatic lymph node[J].Lung Cancer,2007,58(2):205-213.
  • 8Jen LS,Jin YS,Me LY.Cyelooxygenase-2 induces ep1 and her-2/neu-dependent vascular endothelial growth factor-c up-regulation:a novel mechanism of lymphangiogenesis in lung adenocarcinoma[J].Cancer Research,2004,64:554-564.
  • 9Timoshenko AV,Chakraborty C,Wagner GF.COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast Cancer[J].British J Cancer,2006,94:1154-1163.

二级参考文献10

  • 1杨丹,韩立敏.1969-2003年子宫内膜癌发病率及发病因素分析[J].复旦学报(医学版),2005,32(4):479-480. 被引量:33
  • 2Rodrigues S, Bruyneel E, Rodrigue CM, et al. Cyclooxygenase 2 and cancinogenesis [ J ]. Bull Cancer, 2004,91 :s61-76
  • 3Ebert AD, Bartley J, David M. Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis:new questions-old answers[ J]. Eur J Obstet Gynecol Reprod Biol,2005,122 : 144-150
  • 4Brueggenmeier R, Richards J, Petrel T. Aromatase and cyclooxygenases: enzymes in breast cancer [ J ]. J Steroid Biochem Mol Biol,2003,86:501-507
  • 5Chishima F, Hayakawa S, Sugita K, et al. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients [ J ]. Am J Reprod Immunol, 2002,48 : 50-56
  • 6Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer[ J]. Cancer Res,2002 ,62 :632-635
  • 7Mazhar D, Ang R, Waxman J. COX inhibitors and breast cancer[ J ]. Br J Cancer,2006,94:346-350
  • 8Pathirage N, Di Nezza LA, Salmonsen LA, et al. Expression of aromatase, estrogen receptors, and their coaetivatons in patients with endometrial cancer[ J ]. Fertil Steril,2006,86:469-472
  • 9Giuffre G, Arena F, Scarfi R, et al. Lactoferrin immunoexpression in endometrial carcinomas:relationships with sex steroid hormone receptors (ER and PR),proliferation indices ( Ki-67 and AgNOR) and survival [ J ]. Oncol Rep,2006,16:257-263
  • 10Landen CN Jr, Mathur SP, Richardson MS, et al. Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies [ J ]. Am J Obstet Gynecol, 2003,188 : 1174-1176

共引文献2

同被引文献11

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部